Literature DB >> 15638898

Acute urinary retention: what is the impact on patients' quality of life?

Kay Thomas1, Grenville Oades, Cathy Taylor-Hay, Roger S Kirby.   

Abstract

OBJECTIVE: To evaluate the impact of admission for acute urinary retention (AUR) on patients' health-related quality of life (HRQoL) compared with that on admission for elective surgery for benign prostatic hyperplasia (BPH) and emergency admission for renal colic (RC). PATIENTS AND METHODS: Over a 2-year period, three groups of men were recruited from one institution: group 1, men aged >50 years presenting to the accident and emergency (A&E) department with AUR; group 2, for comparison, men aged >50 years admitted for elective surgery for BPH; and group 3, men aged >40 years presenting to A&E with RC. A self-completed HRQoL questionnaire was administered at five visits (72 h from admission, and 1, 2, 3 and 6 months afterward) over a 6-month follow-up.
RESULTS: Group 1 reported mean pain scores on admission of 7.7, compared with 5.6 for group 2 and 8.3 for group 3. Patients in group 1 had the most investigations and recurrent attendance to A&E throughout the study, compared with almost none for the other two groups. There was a substantial economic burden for group 1; 15% had extra help at home at a mean cost of 403 UK pounds for the duration of the study. For the other domains assessed (e.g. emotions, mental state, general health) groups 1 and 2 were similar.
CONCLUSIONS: An episode of AUR has a measurable impact on patients' HRQoL, which often occurs in the community and therefore may not be appreciated by the urology team providing their care. Further work is therefore required to improve the "patient journey" for those with AUR, and to prevent patients developing AUR in the future.

Entities:  

Mesh:

Year:  2005        PMID: 15638898     DOI: 10.1111/j.1464-410X.2004.05254.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  9 in total

Review 1.  Systematic review and meta-analysis on management of acute urinary retention.

Authors:  P D Yoon; V Chalasani; H H Woo
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-07-21       Impact factor: 5.554

2.  Efficacy of Combination Treatment with Tadalafil and Mirabegron in Patients with Benign Prostatic Hyperplasia Who Presented with Persistent Storage Symptoms After Tadalafil Monotreatment: A Prospective, Multicenter, Open-Labeled Study.

Authors:  Masashi Honda; Yusuke Kimura; Shogo Teraoka; Bunya Kawamoto; Shuichi Morizane; Katsuya Hikita; Atsushi Takenaka
Journal:  Yonago Acta Med       Date:  2022-08-04       Impact factor: 1.371

3.  Ambulatory care program for patients presenting with acute urinary retention secondary to benign prostatic hyperplasia.

Authors:  Jeremy Yuen Chun Teoh; Chi Fai Kan; Bess Tsui; Peter K F Chiu; Chi Yin Man; Simon See Ming Hou; Chi Fai Ng
Journal:  Int Urol Nephrol       Date:  2012-08-23       Impact factor: 2.370

4.  Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia.

Authors:  John M Fitzpatrick; François Desgrandchamps; Kamel Adjali; Lauro Gomez Guerra; Sung Joon Hong; Salman El Khalid; Krisada Ratana-Olarn
Journal:  BJU Int       Date:  2011-11-25       Impact factor: 5.588

5.  Predictors of urgency improvement after Holmium laser enucleation of the prostate in men with benign prostatic hyperplasia.

Authors:  Won Sok Hur; Joon Chul Kim; Hyo Sin Kim; Jun Sung Koh; Sang Hoon Kim; Hyun Woo Kim; Su Yeon Cho; Kang Jun Cho
Journal:  Investig Clin Urol       Date:  2016-10-24

6.  Prophylactic postoperative condom sheet placement: A randomized clinical trial to test a new concept.

Authors:  Hadi Ahmadi Amoli; Farzad Vaghef Davari; Bahare Rahmanian; Amirsina Sharifi; Reza Shariat Moharari; Ehsan Rahimpour; Mahmoud Rahmanian; Shahram Gooran
Journal:  Ann Med Surg (Lond)       Date:  2021-01-19

7.  Acute urinary retention in benign prostatic hyperplasia: Risk factors and current management.

Authors:  K Muruganandham; Deepak Dubey; Rakesh Kapoor
Journal:  Indian J Urol       Date:  2007-10

8.  Effect of dutasteride on clinical progression of benign prostatic hyperplasia in asymptomatic men with enlarged prostate: a post hoc analysis of the REDUCE study.

Authors:  Paul Toren; David Margel; Girish Kulkarni; Antonio Finelli; Alexandre Zlotta; Neil Fleshner
Journal:  BMJ       Date:  2013-04-15

9.  Management of the complications of BPH/BOO.

Authors:  Mark J Speakman; Xi Cheng
Journal:  Indian J Urol       Date:  2014-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.